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Background: The total flavonoids from ethanol extract of the aerial part of Ziziphora clinopodioides Lam.
(Lamlaceae) (Xintahua) showed protective activities against rat acute myocardial ischemia in rats. This study aims to
isolate acacetin, a flavonoid, from the aerial part of Z. clinopodioides, to develop an HPLC method for its detection,
and to evaluate its protective effects on neonatal rat cardiomyocytes.
Methods: Sephadex LH-20 silicagel and pillar layer chromatography silica gel were applied for the isolation and
purification of acacetin and its structure was elucidated on the basis of 1H and 13C NMR spectroscopy. The content
of acacetin in Z. clinopodioides collected from three different origins was determined by HPLC. The neonatal rat
cardiomyocytes were isolated and cultured in vitro to establish a hypoxia/reoxygenation injury model. The viability
of cardiomyocytes was measured by the MTT method. Changes of malondialdehyde (MDA) content in the medium
were also determined.
Results: The acacetin content in various batches of Z. clinopodioides ranged from 45.50 to 47.41 μg/g. Acacetin of
25, 10, 5 μg/mL significantly decreased the MDA content in a model of hypoxia/reoxygenation injury (P < 0.001,
P < 0.001 and P = 0.033, respectively).
Conclusions: Acacetin protects neonatal cardiomyocytes from the damage induced by hypoxia/reoxygenation
stress through reduction of lipid peroxidation and enhancement of the antioxidant activity.
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Ziziphora clinopodioides Lam. (Lamiaceae) (Xintahua) is
among the commonly used herbal drugs in Traditional
Uighur Medicine and Traditional Kazak Medicine, with
efficacy for the treatment of hypertension, fever, edema,
heart disease, neurasthenic, insomnia, tracheitis, lung ab-
scess and hemorrhoids [1,2]. The pharmacologically active
ingredients of Z. clinopodioides consist of a large number
of iridoids, phenolic and flavonoid compounds, including
chrysin 7-O-rutinoside, linarin, diosmin, methyl 4-
hydroxy-3,5-dimethoxybenzoate, 7-O-methylsudachitin
(4′,5-dihydroxy-3′,6,7,8-tetramethoxyflavone), thymonin* Correspondence: xueguipengxx@126.com
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unless otherwise stated.(4′,5,6-trihydroxy-3′,7,8-trimethoxyflavone), caffeic acid
and luteolin (3′,4′,5,7-tetrahydroxyflavone) [3-5].
The trichloromethane (CHCl3) and ethyl acetate (EtOAc)
portions from the ethanol extract of the aerial part of Z.
clinopodioides showed protective effects on rat acute myo-
cardial ischemia and neonatal rat cardiomyocytes [6]. De-
tailed analysis indicated that the total flavonoids were the
primary contributor to the observed activities [7].
This study aims to isolate acacetin, a flavonoid, from
the aerial part of Z. clinopodioides, to develop a HPLC
method for its detection, and to evaluate its protective
effects on neonatal rat cardiomyocytes.Methods
Standards and reagents
MTT was purchased from Amresco LLC (Pennsylvania,
USA). Trypsin was from Amresco LLC (Pennsylvania,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Pharmaceutical Group Corporation (Shijiazhuang, China).
DMEM (high glucose and low glucose) was from Invitro-
gen Corporation (Carlsbad, USA). Ampicillin sodium for
injection was produced from China-promise Pharmaceut-
ical Industry (Shijiazhuang, China). Malondialdehyde
(MDA) was provided from the Nanjing Jiancheng Bio-
engineering Institute (Nanjing, China). Acacetin was pre-
pared in the Key Laboratory of Xinjiang Uighur Medicine
(Urumqi, China). HPLC grade methanol and acetonitrile
were purchased from Fisher Scientific (New Jersey, USA).
Water (0.055 μS/cm) was purified by a Milli-Q system
fromMillipore (New Jersey, USA). Sephadex LH-20 silica-
gel was from Amersham Pharmacia Biotech (USA). Pillar
layer chromatography silica gel (100-200 mesh) was from
Qingdao Marine Chemical Plant (China). All other chemi-
cals were of analytical grade.
Plant materials
Two batches of Z. clinopodioides were collected at the
Astronomical Observatory (87°10′40″E, 43°28′14″N,
with altitude of 2076 m) and the Chrysanthemum terrace
(87°08′38″E, 43°27′14″N, with altitude of 2308 m), South
Mountain of Tianshan Mountains in Urumqi, China, in
September and August 2010. Another batch was from
Xiao Dong Gou (88°07′57″E, 47°56′46″N, with altitude of
970 m) of Altai Mountains in Alaty, China, in August
2010. The plant materials were identified by associate re-
searcher Jiang He (Xinjiang Institute of Materia Medica,
Urumqi, China), according to Hudaberbi et al. [8], and
voucher specimens (no. 100954, 100988, 100990, succes-
sively) were deposited in the plant herbarium, Institute of
Metaria Medica.
Apparatus
NMR nuclear magnetic resonance was measured using
JEOL ECP-500, INOVA400 and INOVA-600 (Varian,
USA). Melting points were measured with a semi-
automatic melting point apparatus (YanagimotoMFG Co.,
uncorrected. HPLC analysis was performed using a
Shimadzu-LC 2010C HPLC (Shimadzu, Japan) system. A
BS124S Electronic Balance (Sartorius, Germany) was used
for analysis. A DG-5031 ELISA Reader (Nanjing Huadong
Electronics Group Medical Equipment Co., Ltd., China)
and Shimadzu UV-2501 (Shimadzu, Japan) were used for
cardiomyocyte experiments.
Animals
Neonatal Sprague-Dawley rats (1-3 days old) of either
sex were maintained under standard environmental con-
ditions. All animals were purchased from the Experi-
mental Animal Centre of Xinjiang Medical University
(Urumqi, China). Certificate Number: SCXK (Xin) 2003-
2001. The study protocols were approved by the EthicsCommittee on Animal Experiments, Xinjiang Material
Medica, China (no.20110515).
Extraction and isolation
The air-dried aerial portion of Z. clinopodioides (10 kg) was
extracted with water and then the residue was extracted
withmethanol (MeOH) under reflux. Themethanol extract
was suspended in water and then successively extracted
with CHCl3 and EtOAc. Then, the solution was vacuum-
distilled using a rotary vacuum evaporator (Rotavapor R-
220; Buchi, Switzerland) to yield the CHCl3 fraction
(142.5 g) and EtOAc fraction (138.5 g). The EtOAc fraction
was purified on silica gel eluted with a gradient of CHCl3-
MeOH. Eluates were combined according to thin layer
chromatography (TLC) behavior using two solvent systems
CHCl3-MeOH (97:3) to offer compound 1 (320mg).
Sample preparation for determination of acacetin
Dried powder (1.0 g) of the aerial portion of Z. clinopo-
dioides was refluxed in 30 mL of methanol for 1 h after
soaking for 20 min. After extraction, solvent was added to
the extraction vessel until the final weight was equal to the
starting weight to counter solvent loss. The extract was
thoroughly mixed on a vortex mixer, and filtered through a
0.45 μm syringe filter prior to HPLC injection.
HPLC analysis of acacetin
All experiments were conducted with a Shimadzu-LC
2010C HPLC system. The mobile phase consisted of
acetonitrile (A) and water with 1.0% glacial acetic acid (B),
with the proportion of A:B held at 37:63. The chromato-
graphic separation was performed using a YMC-Pack
ODS-A (4.6 × 250 mm, 5 μm) column with a flow rate of
1.0 mL/min. The column temperature was maintained at
35°C. All analytes were monitored at 326 nm.
Calibration curves
Stock standard solutions of acacetin were prepared in
MeOH and diluted to different concentrations to build
calibration curves, e.g., plotting the peak areas versus the
concentrations of each analyte.
Stability test
Sample was analyzed using the developed method to
verify the stability of the sample. The stability test was
carried out by analyzing the sample at 0, 2, 4, 8, and
24 h. The relative standard deviations (RSDs) of peak
areas at different times were calculated.
Precision test
Intra-day and inter-day variations were used to deter-
mine the precision of the developed method. The intra-
day precision or inter-day precision was determined by











0.02257 0.01168 0.03471 103.92
0.02235 0.01168 0.03425 101.88
0.02226 0.01168 0.03430 103.10
0.02213 0.02336 0.04566 100.72
0.02195 0.02336 0.04488 98.14
0.02186 0.02336 0.04460 97.33
0.02252 0.03504 0.05735 99.40
0.02253 0.03504 0.05827 102.01
0.02222 0.03504 0.05773 101.35
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secutive days, respectively.
Accuracy test
The accuracy of the developed method was evaluated by
spike recovery. Acacetin was added into 0.5 g of sample.
Then, the mixtures were extracted and analyzed. The
spiked recovery was calculated as follows:
Recovery %ð Þ ¼ ½ amount yield−amount originalð Þ
 amount spiked  100%
Cell culture
Primary cultures of neonatal rat cardiomyocytes were pre-
pared from the ventricles of 1 to 3-day-old Sprague-
Dawley rats as previously described [9,10]. The cells were
pre-plated three times for 30 min in a humidified incuba-
tor (95% air/5% CO2 at 37°C) in DMEM supplemented
with 2 mmol/L L-glutamine, 10% (v/v) foetal calf serum
and penicillin/streptomycin (100 U/mL) to minimise
fibroblast contamination. Cardiomyocyte-rich cultures
(>90%) were plated onto fibronectin-coated 96-well plates,
100 μL per well, at a final density of 1.00 × 105 cells per
cm2 in supplemented DMEM [11,12].
Cell viability
The culture solution was discarded after 24 h co-
cultivation of myocardial cells and different concentra-
tions of acacetin, and then 180 μL DMEM and 20 μL MTT
were added to each well for 4 h cultivation. The super-
natant was discarded and 150 μL DMSO was added to
each well, mixed evenly, and the absorbance (A) was mea-
sured at 570 nm within 10 min using a DG-5031 ELISA
Reader [13].
Model of hypoxia/reoxygenation injury
After cultivation for 72 h, the medium was exchanged
with one that was hypoxic (culture medium saturated
with high concentrations of N2 in advance), and the so-
lution was placed in a hypoxic culture box (99.99% N2)
for 120 min. Then, the medium was replaced with one
saturated with pure O2, and the cells were exposed to a
normoxic atmosphere containing 95% air and 5% CO2 at
37°C (reoxygenation) for 30 min. A thiobarbituric acid
(TBA) method was used to determine the content of
MDA [6].
Cell experimental protocol
Experimental doses of acacetin were investigated using a
cell viability test. The cells were divided into five experi-
mental groups: group I served as a control (normal cell
culture group, incubation for 3 h in the incubator),
group II served as the myocardial cell injury controlgroup (hypoxic 2 h, and reoxygenation 1 h), groups III,
IV and V were treated with three different doses (25, 10,
and 5 μg/mL,respectively) of acacetin (hypoxic 2 h, and
reoxygenation 1 h). The inhibition rate was calculated
from the absorbance of the medium containing added
acacetin over the medium of the control (group I).
Statistical analysis
The results were reported as the mean ± standard deriv-
ation (SD) of at least three measurements. The analysis
of MDA data was performed with the SPSS 10.0 statis-
tical package (IBM, USA), while simple linear regression
was performed in Excel (Microsoft, Redmond, WA,




Compound 1 was yellow needle-like crystals. 1H-NMR
(DMSO-d6, 600 M Hz) δ: 12.93 (1H, s, 5-OH), 10.87 (1H,
br s, 7-OH), 8.05 (2H, d, J = 9.0 Hz, H-2′,6′), 7.11 (2H, d,
J = 8.8 Hz, H-3′,5′), 6.89 (1H, s, H-3), 6.51 (1H, d, J =
1.8 Hz, H-8), 6.20 (1H, d, H-3, J = 2.4 Hz, H-6); 13CNMR
(DMSO-d6, 150 M Hz) δ: 181.8 (C-4), 164.2 (C-7), 163.3
(C-2), 162.3 (C-4′), 161.4(C-5), 157.3 (C-9), 128.3 (C-
2′,6′), 122.8 (C-1′), 114.5 (C-3′,5′), 103.8 (C-10), 103.5
(C-3), 98.9 (C-6), 94.0 (C-8). Compound 1 was identified
as acacetin by comparison of its physical and spectral data
with the literature [14,15].
HPLC method validation
Calibration curve, LOD and LOQ
The calibration curve for acacetin was as y = 43237 x +
10969, R2 = 0.9999 (P < 0.001). The test range was 1.168-
12.848 μg/mL. The LOD (S/N = 3) and LOQ (S/N = 10)
was 0.29 μg/mL and 1.17 μg/mL, respectively.
Figure 1 HPLC chromatograms of the aerial part of Z. Clinopodioides. (A) Acacetin. (B) Extract of sample.
Table 2 Content of acacetin in the aerial portion of Z.
clinopodioidesfrom different locations in Xinjiang (n = 3)
Species Location Acacetin (μg/g)
Z. clinopodioides AOa, South Mountain, Urumqi 45.60 ± 0.04
Z. clinopodioides CTb, South Mountain, Urumqi 45.50 ± 0.10
Z. clinopodioides Altai Mountain, Alaty 47.41 ± 0.18
aAO: Astronomical observatory.
bCT: Chrysanthemum terrace.
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The RSD of peak areas at different times were less than
1.13%, indicating that the sample was stable for at least
24 h.
Precision test
The RSD value of intra-day and inter-day precision was
0.11% and 1.64%, respectively, which suggested that the
developed method was precise enough for determining
acacetin in Z. clinopodioides.
Accuracy test
The recoveries of acacetin were 97.33-103.92%, which
indicated the developed method was suitable for deter-
mination of acacetin from Z. clinopodioides (Table 1).
Quantitative analysis
Figure 1A shows an HPLC chromatogram for Acacetin,
Figure 1B shows a chromatogram of extract of sample.
The results of the quantitative analysis of three batchesof Z. clinopodioides are shown in Table 2. No significant
differences of acacetin content in Z. clinopodioides were
found from one batch to another (ranging from 45.50 to
47.41 μg/g) (Table 2).Cell viability result
The cardiomyocyte viability was greater than 50% when
subjected to an acacetin dose less than 12.5 μg/mL
(Table 3).




3.175 6.25 12.5 25.0 50 100 200
Viability (%)1 54.78 52.37 52.93 47.76 45.48 43.11 44.49
1The results reported are the average of three experiments.
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The MDA content was significantly increased from
0.14 ± 21.34 to 30.72 ± 1.40 nmol/Lafter myocardial cell
injury (Table 4). Compared with Group II (30.72 ±
1.40 nmol/L), the MDA content of Group III, Group VI,
and Group V were reduced to 4.00 ± 2.91 nmol/L (P <
0.001), 10.64 ± 3.54 nmol/L (P < 0.001) and 15.45 ±
14.62 nmol/L (P = 0.033), respectively. These results
confirmed that as the treatment concentration of acace-
tin increased, the MDA content in cardiomyocytes de-
creased. At 25 and 10 μg/mL acacetin, a significant
reduction was observed (P < 0.001 and P < 0.001, respect-
ively) (Table 4).
Discussion
Flavonoids are polyphenol compounds, which are widely
distributed in a variety of plants and have many pharma-
cological activities associated with cardiovascular protec-
tion such as antioxidation [16], anti-inflammatory, blood
vessel expansion, arrhythmia inhibition, and antiplatelet
aggregation [17]. Some flavonoids also have antitumor
activities [18,19].
Acacetin exists in plants of asteraceae [20-22], and viola-
ceae [23], but was rarely identified in lamiaceae. Acacetin
is an atrium-selective agent that prolongs the atrial refrac-
tory period without prolonging the corrected QT interval
and effectively prevents atrial fibrillation in anesthetized
dogs after intraduodenal administration. These results in-
dicate that oral acacetin might be a promising atrium-
selective agent for the treatment of AF [24]. However, the
antioxidant activity of acacetin has not been thoroughly
investigated.
In cardiomyocyte injury induced by hypoxia/reoxygena-
tion, which is similar to heart ischemia-reperfusion injuryTable 4 The effect of acacetin on the MDA content in
neonatal rat cardiomyocytes subjected to hypoxia/
reoxygenation injury
Groups Acacetin (μg/mL) MDA (nmol/L)1
I — 0.14 ± 1.34
II — 30.72 ± 1.40
III 25 4.00 ± 2.91**
IV 10 10.64 ± 3.54**
V 5 15.45 ± 14.62*
1Results are expressed as the mean ± S.D (n = 6).
*P < 0.05, significant difference vs. group II.
**P < 0.01 significant difference vs. group II.in vitro, free radical injury was involved [25]. After myocar-
dial ischemia-reperfusion, the body produces oxygen free
radicals (OFR), and OFR-mediated cell membranes and
subcellular membrane lipid peroxidation (LPO), while
MDA is the LPO reaction product induced by OFR attack-
ing the biomembrane. The amount of MDA reflects the de-
gree of LPO, and is usually used to evaluate the degree of
exposure to OFR [26]. In this study, after subjecting the car-
diomyocytes to hypoxia/reoxygenation, the content of MDA
in the medium increased significantly. Treatment with
acacetin prevented the increase in MDA content, hence
improving the antioxidant capacity of the myocardial cells.
Conclusions
Acacetin protects neonatal cardiomyocytes from the dam-
age induced by hypoxia/reoxygenation stress through re-
duction of lipid peroxidation and enhancement of the
antioxidant activity.
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